Cytek Biosciences, Inc. SEC filings CTKB

Cytek Biosciences, Inc. has 464 filings in SEC EDGAR's recent list, going back to Nov 10, 2020. Its latest annual report, Form ARS, was filed on Apr 28, 2026 for the period ended Dec 31, 2025. The latest quarterly report (Form 10-Q) was filed on Nov 4, 2026, covering the quarter ended Sep 30, 2026. The most recent current report (Form 8-K) was filed on Nov 4, 2026 (results of operations). The company's fiscal year ends on December 31.

Cytek Biosciences, Inc. SEC filings
Form Description Filed Period
S-8 Employee stock plan registration Feb 27, 2026 —
S-8 Employee stock plan registration Feb 28, 2025 —
S-8 Employee stock plan registration Mar 14, 2024 —
S-8 Employee stock plan registration Mar 2, 2023 —
S-3ASR Automatic shelf registration Aug 26, 2022 —
S-8 Employee stock plan registration Mar 17, 2022 —
S-8 Employee stock plan registration Jul 23, 2021 —
424B4 Prospectus Jul 23, 2021 —
S-1/A Amended registration statement Jul 19, 2021 —
S-1/A Amended registration statement Jul 14, 2021 —
S-1 Registration statement Jul 2, 2021 —

Showing 11 filings. Main filings leave out insider and ownership forms such as Form 4; choose a type above to see them. Each form opens on SEC.gov. Older filings are on SEC EDGAR.

Company profile

Industry
Laboratory Analytical Instruments (SIC 3826)
Listed as
CTKB (Nasdaq)
Fiscal year ends
December 31
Incorporated in
DE
Headquarters
Fremont, CA
SEC filer status
Accelerated filer
SEC CIK
1831915

Other Laboratory Analytical Instruments companies

Source: SEC EDGAR filings. This is company-reported data, not investment advice.